(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

NOBLE PHARMA

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

NOBLE PHARMA

ST13

US500000099057943

Class

40

Filing

99057943

Registration

8148469

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

19

Latest update

02/25/2026

Trademark type

Combined

Nice classes

40

Filing date

02/26/2025

Registration date

02/24/2026

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/24/2026

Last transaction

02/25/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

First use anywhere

2018-00-00

First use in commerce

2018-00-00

Drawing code

3

Owner type

16

Owner location

Menomonie, WI, US

Examiner

PETTICAN, NATHANIEL VINCIENT

Law office

L80

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of a stylized depiction of a flask with a triangle inside the flask and three bubbles floating above the top of the flask, situated left of the stylized wording "NOBLE PHARMA".

Holders and representatives

Holders

Noble Pharma, LLC

Representatives

Craig Fieschko DeWitt LLP

Technical classification

Nice Classes

Class 40

Vienna Codes

No Vienna codes available.

Goods and services

Class 40

Manufacture of pharmaceuticalsveterinary preparationsanimal feed supplementsanimal dietary supplements to order and/or specification of others

Publications

History of USPTO decisions and trademark events.

19 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/24/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

02/24/2026

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

01/06/2026

PUBO

PUBLISHED FOR OPPOSITION

01/06/2026

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

12/31/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/08/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

10/31/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

10/31/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

10/31/2025

XELG

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED

10/29/2025

XELR

APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED

10/29/2025

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

10/02/2025

GNRT

NON-FINAL ACTION E-MAILED

10/02/2025

CNRT

NON-FINAL ACTION WRITTEN

10/02/2025

DOCK

ASSIGNED TO EXAMINER

10/01/2025

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

09/30/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/30/2025

MAFR

APPLICATION FILING RECEIPT MAILED

02/26/2025

NWAP

NEW APPLICATION ENTERED

02/26/2025

Continuous trademark protection

Get notified about every new filing that threatens NOBLE PHARMA or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.